Reta 10

Retatrutide 10 is supplied as a lyophilized research peptide intended strictly for laboratory and analytical applications. This tri-agonist compound is studied for its interaction with GLP-1, GIP, and glucagon receptor (GCGR) pathways in controlled research environments.

Research Context

Retatrutide is classified as a multi-receptor agonist and is currently explored in metabolic pathway research models involving incretin and glucagon receptor signaling. Ongoing research continues to evaluate receptor-binding characteristics, signaling cascade behavior, and downstream pathway modulation in laboratory settings.

Product Specifications

• Compound: Retatrutide
• Quantity: 10mg per vial
• Format: Lyophilized powder
• Appearance: White to off-white
• Storage: Store in a cool, dry environment prior to reconstitution

Commonly Paired in Research Workflows

• BPC Capsules – frequently selected in complementary laboratory protocols
• MOTS-c – evaluated in cellular energy pathway research models
• NAD+ – commonly studied in mitochondrial research settings

Certificate of Analysis (COA)

Third-party analytical documentation for this batch is available below.

Why Bandit Research

• Competitive laboratory pricing structure
• Transparent documentation
• Discreet U.S.-based fulfillment
• Focused exclusively on research-grade inventory

Frequently Asked Questions

Why does the vial label differ from the Bandit Research branding?

Select products may be supplied in standardized laboratory vials used across our extended inventory formats. Regardless of label variation, all products offered through Bandit Research are sourced and quality-verified under the same internal standards and documentation requirements.

Research Use Only. This product is intended strictly for laboratory research purposes. Not for human consumption, medical use, or veterinary application.